For Research Use Only. Not for use in Diagnostic Procedures. Trademarks and/or registered trademarks mentioned herein are the property of AB Sciex Pte. Ltd., or their respective owners, in the United States and/or certain other countries. For information on availability, please contact your local representative.
AB SCIEX™ is being used under license. Beckman Coulter® is being used under license. ICAT™ is a trademark of the University of Washington and is exclusively licensed to AB Sciex Pte. Ltd.
© 2019 DH Tech. Dev. Pte. Ltd.
ISB and SCIEX have signed a multi-year agreement to collaborate on the development of methods and technology in proteomics mass spectrometry. Learn more.
Medical care is expected to become more personalized and better able to help prevent the onset of diseases in the future, thanks to groundbreaking research into P4 medicine underway by world-renowned scientists at the Institute for Systems Biology, including National Medal of Science award winner Leroy Hood, MD, PhD., and ISB proteomics research director, Robert Moritz, PhD., and now supported by a new collaboration with SCIEX, a global leader in analytical technology.
ISB and SCIEX have signed a multi-year agreement to collaborate on the development of methods and technology in proteomics mass spectrometry with the goal to redefine biomarker research and complement genomics through fully comprehensive quantitative proteomics analysis. This will help advance the development of a new approach to medical care.
ISB's concept of P4 medicine promises to provide deep insight into disease mechanisms on the path to develop medical care that is predictive, personalized, preventive and participatory (the four "P"s) - a pioneering vision that requires a combination of analytical tools, workflows, databases, collaborations and computational strategies.
"With breakthroughs in translating research into clinical relevance, P4 medicine is expected to enable the creation of a virtual cloud of billions of data points around each individual as the basis for straightforward predictions about health and disease," said Dr. Hood, ISB president and co-founder. In December, he was named a recipient of the National Medal of Science, which is the highest honor the President of the United States can bestow on a scientist, in recognition of visionary work for the advancement of science.
Led by Dr. Hood, ISB's groundbreaking research is being accelerated by SWATH® Acquisition, a data-independent acquisition (DIA) mass spectrometry workflow that can quantify virtually all detectable peptides and proteins in a complex sample - all in a single analysis.
"Quantifying enormous numbers of protein analytes at the same time is a critical need to accelerate P4 medicine and the democratization of proteomics, a revolution that is akin to the sequencing of the genome and the democratization of DNA," added Dr. Hood. "SWATH® is a game-changing technique that essentially acts as a protein microarray and is the most reproducible way to generate comprehensive quantitation of the entire proteome. It generates a digital record of the entire proteome that can be mined retrospectively for years to come."
ISB's know-how in systems biology and informatics will support the development of SWATH® libraries, similar to its highly regarded SRMAtlas project for the human proteome, pioneered by Rob Moritz and his collaborators, and the proteomes of other clinically-relevant organisms. "With complete proteome-wide libraries, ISB provides the basis to support comprehensive SWATH® analysis," said Dr. Moritz, ISB Proteomics Research Director.
Committed to an open policy of sharing data and methods, ISB will make the SWATH® libraries available to the global scientific community to accelerate the use of SWATH® for other biological research. Utilizing the depth in proteomics technology development and underpinned by the extensive proteomics computational resources in data interpretation tools, standards initiatives and database development under the leadership of Dr. Moritz, ISB will develop new SWATH® technologies and tools to enable the community to quickly adopt comprehensive quantitative proteome analysis.
"Having the proteomics data standardized across laboratories and across samples really enables us to quantitate entire proteomes at a level that hasn't been done before," said Dr. Moritz. "We aim to define markers that can predict whether a patient will respond to a certain treatment or not, and applying SWATH® will play a big part in taking our advancements to another level. Not only can we now complement the breadth of genomics, but we will have the much-needed libraries and software development going forward to make data-sharing quite easier and standardized."
As a trusted partner with academic researchers, SCIEX has formed this strategic alliance with Dr. Hood, Dr. Moritz and their distinguished ISB colleagues through the SCIEX Academic Partnership Program to help broaden the availability of new technologies to researchers delving into omics research around the world.
"What ISB does with SWATH® will set a new benchmark in proteomics research," said Rainer Blair, President of SCIEX. "Our collaboration with ISB will help drive SWATH® into the mainstream of analytical science and make comprehensive, reproducible and simplified omics data more accessible to biologists around the world."
ISB will be using the SCIEX TripleTOF® 5600+ System and an Eksigent ekspertTM nano-LC 400 System as the instrument platforms on which to conduct the protein identification and quantitation. The TripleTOF 5600+ System provides the high speed necessary for SWATH® Acquisition. TripleTOF technology combines high speed and high sensitivity with high resolution and accurate mass. ISB also plans to use SelexIONTM technology, a recent advancement in differential ion mobility, in the future to advance its research.
About P4 Medicine
P4 Medicine - i.e. medicine that is Predictive, Preventive, Personalized and Participatory -- is emerging out of the convergence of systems biology, the increasing activation of networked consumers and the digital revolution in communications and information technology. Historically, human biology was a black box about which little was known apart from surface manifestations of disease. That black box is now being opened by systems biology. P4 medicine looks inside that black box for each individual using the pioneering capability of systems biology to generate actionable understandings of disease and wellness as a continuum of network states unique in time and space to each individual human being.
About the Institute for Systems Biology
The Institute for Systems Biology (ISB) is a world-renowned, non-profit research institute headquartered in Seattle that is dedicated to the study and application of systems biology. Founded in 2000, ISB seeks to unravel the mysteries of biology while identifying strategies for predicting and preventing diseases, solving energy and environmental issues, and improving K-12 science education. ISB's systems approach integrates biology, computation and technological development, enabling scientists to analyze all elements in a biological system rather than one gene or protein at a time. ISB has 10 faculty members and about 230 staff. Follow ISB on Twitter @ISBUSA and Facebook.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company's global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 25 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. Follow SCIEX on Twitter @ABSCIEX and on Facebook and LinkedIn
© 2013. AB SCIEX. AB Sciex Instruments Are For Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.
SCIEX Media Contact
Director of Public Relations
ISB Media Contact
Director of Communications
A new password has been sent to your email.
You have added a user.
This serial number could not be found. Would you like to submit the case anyway?
Your password has been updated.
Your account is now created.
A verification link has been sent to your email.
A new password has been sent to your email.
Your insturment has been removed.
Your privacy settings are now updated.
Software has already been registered to another instrument. Please check your AID and try again.
If you want to change the License Key to another instrument, please submit a new case.
Software has already been registered to the instrument selected.
Please check your instrument's software by going to the Instruments page and selecting the instrument in your "My Instruments" section. Here you will see a Software tab where you can view your instrument's software information.
You can also go to the Registered Software page to view software associated with your instrument(s).
If you are not finding what you are looking for, please submit a new case.